For in vitro diagnostic use. Others Elecsys CA 15-3 II IVD Elecsys® CA 15-3 II CPS_000448 09 755 594 190 9 755 594 190 09755594190 9755594190 09755594190 CA 15-3 G2 Elecsys E2G 100 V1 CA 15-3 G2 Elecsys E2G 100 V1 07613336218334 Reagents, kits 100 tests cobas e 402/801 true 07 027 001 214 7 027 001 214 07027001214 7027001214 07027001214 CA 15-3 G2 Elecsys E2G 300 Elecsys CA 15-3 II 07613336194126 Reagents, kits 300 tests cobas e 402/801 true 03 045 838 122 3 045 838 122 03045838122 3045838122 03045838122 CA 15-3 G2 Elecsys cobas e 100 Elecsys CA 15-3 II 04015630918218 Reagents, kits 100 tests cobas e 411/601/602 true 07 027 001 188 7 027 001 188 07027001188 7027001188 07027001188 CA 15-3 G2 Elecsys E2G 300 Elecsys CA 15-3 II 07613336194133 Reagents, kits 300 tests cobas e 402/801 true 07 027 001 190 7 027 001 190 07027001190 7027001190 07027001190 CA 15-3 G2 Elecsys E2G 300 Elecsys CA 15-3 II 04015630939961 Reagents, kits 300 tests cobas e 402/801 true 03 045 838 160 3 045 838 160 03045838160 3045838160 03045838160 CA 15-3 G2 Elecsys cobas e 100 Elecsys CA 15-3 II 04015630934379 Reagents, kits 100 tests cobas e 411/601/602 true 03 045 838 214 3 045 838 214 03045838214 3045838214 03045838214 CA 15-3 G2 Elecsys cobas e 100 Elecsys CA 15-3 II 07613336161159 Reagents, kits 100 tests cobas e 411/601/602 true 03 045 838 188 3 045 838 188 03045838188 3045838188 03045838188 CA 15-3 G2 Elecsys cobas e 100 Elecsys CA 15-3 II 07613336161142 Reagents, kits 100 tests cobas e 411/601/602 09755594501 Elecsys CA 15-3 II en 1 FF0000000710AA0E FF0000000710AA0E 09755594190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum, Li‑heparin and EDTA plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09755594500 Elecsys CA 15-3 II en 1 FF000000066E350E FF000000066E340E 09755594190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027001500 Elecsys CA 15-3 II en 8 FF0000000568140E FF0000000568140E 07027001190 07027001214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 03045838500 Elecsys CA 15-3 II en 24 FF0000000567D00E FF0000000005540E 03045838122 03045838214 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027001500 Elecsys CA 15-3 II en 7 FF000000049F840E FF000000044B3D0E 07027001190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027001501 Elecsys CA 15-3 II en 4 FF0000000566510E FF0000000262F80E 07027001190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum, Li‑heparin and EDTA plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 03045838501 Elecsys CA 15-3 II en 7 FF00000006F8D20E FF0000000003550E 03045838160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User Profile

Select your user profile

Elecsys^® CA 15-3 II

Overview

Ordering Information

Technical Documents

Access important product documentation including relevant certificates and other resources.

Compatible Instruments

Related products

Contact us